JPA Chairman Opposes Complete Lifting Of OTC Internet Sales Ban In Japan
This article was originally published in PharmAsia News
Japan Pharmaceutical Association Chairman Kodama Takashi expressed his opposition against the complete lifting of the ban on Internet sales of OTC drugs at a press conference on April 25.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Genfit will delay unblinding of data from its nearly complete Phase III study of elafibranor to get insight from the FDA on statistical methods in order to optimize its NDA.
Revolution has just one drug in the clinic, but its focus on KRAS excited IPO investors. Also, Deciphera’s $175m offering leads recent follow-ons and Spruce raises $88m in venture capital.